UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12906) 12906
Book Chapter (60) 60
Conference Proceeding (36) 36
Dissertation (33) 33
Publication (18) 18
Government Document (7) 7
Newsletter (7) 7
Book / eBook (6) 6
Web Resource (5) 5
Magazine Article (4) 4
Newspaper Article (2) 2
Streaming Video (2) 2
Book Review (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10068) 10068
science & technology (9177) 9177
camptothecin - analogs & derivatives (8532) 8532
life sciences & biomedicine (8481) 8481
camptothecin - administration & dosage (5024) 5024
oncology (4826) 4826
female (4722) 4722
male (4413) 4413
camptothecin - pharmacology (3706) 3706
biological and medical sciences (3664) 3664
antineoplastic combined chemotherapy protocols - therapeutic use (3641) 3641
middle aged (3504) 3504
medical sciences (3359) 3359
aged (3283) 3283
animals (3086) 3086
adult (2695) 2695
irinotecan (2660) 2660
chemotherapy (2634) 2634
camptothecin (2597) 2597
antineoplastic agents (2446) 2446
camptothecin - therapeutic use (2402) 2402
pharmacology. drug treatments (2396) 2396
colorectal neoplasms - drug therapy (2181) 2181
pharmacology & pharmacy (2040) 2040
cancer (1978) 1978
treatment outcome (1868) 1868
fluorouracil - administration & dosage (1805) 1805
tumors (1790) 1790
camptothecin - adverse effects (1784) 1784
mice (1703) 1703
cell line, tumor (1502) 1502
colorectal neoplasms - pathology (1412) 1412
colorectal cancer (1390) 1390
antineoplastic combined chemotherapy protocols - adverse effects (1350) 1350
leucovorin - administration & dosage (1239) 1239
camptothecin - pharmacokinetics (1184) 1184
topoisomerase i inhibitors (1156) 1156
organoplatinum compounds - administration & dosage (1151) 1151
biochemistry & molecular biology (1142) 1142
antineoplastic agents - pharmacology (1128) 1128
antineoplastic agents, phytogenic - pharmacology (1088) 1088
antineoplastic agents, phytogenic - administration & dosage (1080) 1080
antineoplastic combined chemotherapy protocols - administration & dosage (1074) 1074
camptothecin - chemistry (1072) 1072
drug administration schedule (1068) 1068
apoptosis (1008) 1008
dose-response relationship, drug (1007) 1007
apoptosis - drug effects (953) 953
antineoplastic agents - therapeutic use (928) 928
antineoplastic agents, phytogenic - therapeutic use (923) 923
physical sciences (910) 910
chemistry (908) 908
lung neoplasms - drug therapy (867) 867
aged, 80 and over (846) 846
analysis (819) 819
disease-free survival (816) 816
research (800) 800
cisplatin - administration & dosage (798) 798
care and treatment (793) 793
neoplasms - drug therapy (778) 778
tumor cells, cultured (775) 775
adenocarcinoma - drug therapy (774) 774
survival rate (765) 765
dna damage (758) 758
fluorouracil - therapeutic use (758) 758
gastroenterology. liver. pancreas. abdomen (749) 749
deoxycytidine - analogs & derivatives (734) 734
liver neoplasms - secondary (727) 727
neoplasm staging (720) 720
dna topoisomerases, type i - metabolism (715) 715
antineoplastic agents - administration & dosage (711) 711
metastasis (689) 689
neoplasm metastasis (687) 687
bevacizumab (678) 678
medicine & public health (672) 672
cell biology (661) 661
stomach. duodenum. small intestine. colon. rectum. anus (658) 658
cell survival - drug effects (657) 657
enzyme inhibitors - pharmacology (643) 643
retrospective studies (627) 627
liver neoplasms - drug therapy (610) 610
survival analysis (591) 591
mice, nude (581) 581
antimitotic agents (567) 567
antineoplastic agents, phytogenic - pharmacokinetics (567) 567
time factors (564) 564
drug resistance, neoplasm (560) 560
general aspects (558) 558
antineoplastic agents, phytogenic - adverse effects (551) 551
drug delivery systems (539) 539
drug therapy (539) 539
antibodies, monoclonal, humanized (538) 538
prognosis (537) 537
fluorouracil - adverse effects (529) 529
rats (526) 526
camptothecin - metabolism (524) 524
combined modality therapy (523) 523
deoxycytidine - administration & dosage (520) 520
camptothecin - toxicity (511) 511
drugs (509) 509
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12279) 12279
Japanese (859) 859
Chinese (228) 228
French (95) 95
German (63) 63
Russian (37) 37
Italian (33) 33
Hungarian (14) 14
Portuguese (14) 14
Spanish (13) 13
Korean (12) 12
Czech (4) 4
Dutch (3) 3
Lithuanian (3) 3
Polish (3) 3
Danish (2) 2
Croatian (1) 1
Norwegian (1) 1
Romanian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 14, pp. 2311 - 2319
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | General aspects | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Immunomodulators | Tumors | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Science translational medicine, ISSN 1946-6234, 12/2020, Volume 12, Issue 572
Journal Article
Journal Article
Investigational new drugs, ISSN 0167-6997, 8/2013, Volume 31, Issue 4, pp. 986 - 1000
Journal Article
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 19, pp. 3843 - 3854
clinical trial | trophoblastic cell‐surface antigen (Trop‐2) | epithelial cancers | antibody‐drug conjugate | IMMU‐132 (sacituzumab govitecan) | SN‐38 | trophoblastic cell-surface antigen (Trop-2) | SN-38 | antibody-drug conjugate | IMMU-132 (sacituzumab govitecan) | Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasms - metabolism | Humans | Middle Aged | Half-Life | Immunoconjugates - pharmacokinetics | Male | Response Evaluation Criteria in Solid Tumors | Immunoconjugates - administration & dosage | Glucuronosyltransferase - genetics | Antineoplastic Agents, Phytogenic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Time Factors | Antibodies, Monoclonal, Humanized - pharmacokinetics | Camptothecin - blood | Aged, 80 and over | Antigens, Neoplasm - metabolism | Adult | Camptothecin - administration & dosage | Female | Neutropenia - chemically induced | Antineoplastic Agents, Phytogenic - pharmacokinetics | Antineoplastic Agents, Phytogenic - adverse effects | Camptothecin - analogs & derivatives | Immunoconjugates - adverse effects | Camptothecin - pharmacokinetics | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Cell Adhesion Molecules - metabolism | Neoplasms - drug therapy | Irinotecan | Aged | Immunoglobulin G - metabolism | Usage | Care and treatment | Safety and security measures | Analysis | Epithelial tumors | Pharmacokinetics | Antibody-drug conjugates | Camptothecin | Antigens | Toxicity | Immunoglobulin G | Breast cancer | Pharmacology | Metastasis | Criteria | Patients | Cell surface | Metastases | Uridine | Safety | Solid tumors | Drug dosages | Cancer | Tumors | Half life | Neutropenia | Glucuronosyltransferase | Index Medicus | Abridged Index Medicus
Journal Article